Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Transfusion in critical care: Past, present and future

    Research output: Contribution to journalReviewResearchpeer-review

  2. Red blood cell storage duration and long-term mortality in patients undergoing cardiac intervention: a Danish register study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The wound healing effect of local leukocyte platelet-rich plasma after total hip arthroplasty: A randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Long-term neurotoxicity and quality of life in testicular cancer survivors-a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Plasma as a resuscitation fluid for volume-depleted shock: Potential benefits and risks

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations

OBJECTIVES: The primary objective of this feasibility study was to identify quality of life (QoL) scores and symptom scales as tools for measuring patient-reported outcomes (PRO) associated with haemoglobin level in chemotherapy-treated cancer patients. Secondary objectives included comparing QoL and symptoms between randomisation arms.

BACKGROUND: Anaemia in cancer patients undergoing chemotherapy is associated with decreased QoL. One treatment option is red blood cell transfusion (RBCT). However, the optimal haemoglobin trigger for transfusion is unknown.

METHODS: Patients were randomised to a haemoglobin trigger for RBCT of either < 9·7 g dL(-1) (arm A) or < lower normal level, female: 11·5 g dL(-1) , male: 13·1 g dL(-1) (arm B). Four PROs were used: Functional Assessment of Cancer Therapy-General (FACT-G) and the FACT-Anaemia (FACT-An), a Numeric Rating Scale on symptoms of anaemia and self-reported Performance Status (PS). The association between haemoglobin and PRO variables was assessed using a linear mixed model with random effects.

RESULTS: A total of 133 patients were enrolled, of which 86 patients received RBCT (28 in arm A, 58 in arm B). Baseline questionnaires were filled out in 79·7% of cases. Haemoglobin levels were significantly correlated with FACT-An, FACT-An Total Outcome Index (TOI), Functional Well-Being, fatigue and PS. Improvement on several PRO variables was observed in both arms after RBCT, with clinically minimal important differences observed in FACT-G, Physical Well-Being, FACT-An, FACT-An TOI, fatigue and dyspnoea.

CONCLUSIONS: QoL scores of physical and functional domains as well as self-reported anaemia-related symptoms correlated well with haemoglobin level in chemotherapy-treated cancer patients.

Original languageEnglish
JournalTransfusion medicine (Oxford, England)
Volume28
Issue number3
Pages (from-to)208-215
ISSN0958-7578
DOIs
Publication statusPublished - 2018

    Research areas

  • Journal Article

ID: 52036922